Improved survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant

Study shows that excessively high BMI is also associated with type 1 diabetes—not just the type 2
5 June 2022
Pandemic politics: People in Republican counties were more likely to die from COVID-19, new analysis shows
6 June 2022

Improved survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

Comments are closed.